title: Hyperinsulinaemia causes a preferential increase in hepatic P4501A2 activity.
abstract: Male NEDH (New England Deaconess Hospital) rats were transplanted with a radiation-induced tumour from a donor male rat and were killed 18 days following transplantation. At the time of killing the insulinoma-bearing animals were severely hypoglycaemic but plasma ketone levels were normal. Insulinoma-bearing animals exhibited higher hepatic O-deethylation of ethoxyresorufin and N-demethylation of ethylmorphine activities when compared to control animals. Similarly, hepatic microsomal preparations from insulinoma-bearing rats were more efficient than control animals in converting the promutagen 2-amino-6-methyldipyrido[1,2-a:3',2']imidazole (Glu-P-1) to mutagenic intermediates in the Ames test. Immunoblot analysis employing polyclonal antibodies against the P4501A and P453A families revealed that insulinoma-bearing rats had higher hepatic P4501A2 apoprotein levels. No major differences in P4503A1 apoprotein levels between insulinoma-bearing and control rats were noted. Subcutaneous administration of insulin to male Wistar rats gave rise to a modest increase in ethoxyresorufin O-deethylase activity and in the ability to activate Glu-P-1 to mutagens in the Ames test. Immunoblot analysis revealed an increase in hepatic P4501A2 apoprotein levels following the treatment with insulin. It is concluded that insulinoma-bearing rats display high P4501A2 activity and the hyperinsulinaemia that characterize this condition is responsible for the effect. Moreover, administration of insulin to other strains of rat, such as Wistar, also enhances P4501A2 activity, presumably as a result of hyperinsulinaemia.
authors.affiliation: Division of Toxicology, School of Biological Sciences, University of Surrey, Guildford, Northern Ireland.
authors.forename: C R
authors.initials: CR
authors.lastname: Barnett
authors.forename: J
authors.initials: J
authors.lastname: Wilson
authors.forename: C R
authors.initials: CR
authors.lastname: Wolf
authors.forename: P R
authors.initials: PR
authors.lastname: Flatt
authors.forename: C
authors.initials: C
authors.lastname: Ioannides
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D007328:Insulin / Q000008:administration & dosage / Q000097:blood*; D007340:Insulinoma / Q000201:enzymology*; D007527:Isoenzymes / Q000378:metabolism*; D007659:Ketones / Q000097:blood; D008099:Liver / Q000201:enzymology*; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D006899:Mixed Function Oxygenases / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000201:enzymology*; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D001786:Blood Glucose; D007328:Insulin; D007527:Isoenzymes; D007659:Ketones; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases